News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
834,517 Results
Type
Article (85792)
Company Profile (649)
Press Release (748076)
Section
Business (232091)
Career Advice (4121)
Deals (39691)
Drug Delivery (124)
Drug Development (90701)
Employer Resources (195)
FDA (17959)
Job Trends (17295)
News (395291)
Policy (39616)
Tag
Academia (2977)
Alliances (56576)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (113)
Approvals (17937)
Artificial intelligence (194)
Bankruptcy (400)
Best Places to Work (12521)
Biotechnology (447)
Breast cancer (199)
Cancer (1603)
Career advice (3523)
CAR-T (130)
Cell therapy (381)
Clinical research (72216)
Collaboration (639)
Compensation (315)
COVID-19 (2809)
C-suite (153)
Data (1437)
Diabetes (153)
Diagnostics (6713)
Earnings (94531)
Employer resources (166)
Events (127366)
Executive appointments (486)
FDA (18700)
Funding (534)
Gene therapy (271)
GLP-1 (685)
Government (5051)
Healthcare (20720)
Infectious disease (2901)
Inflammatory bowel disease (134)
Interviews (810)
IPO (17665)
Job creations (5182)
Job search strategy (2859)
Layoffs (510)
Legal (10039)
Lung cancer (241)
Manufacturing (233)
Medical device (14313)
Medtech (14318)
Mergers & acquisitions (22172)
Metabolic disorders (494)
Neuroscience (1787)
NextGen: Class of 2025 (7661)
Non-profit (5055)
Northern California (1864)
Obesity (271)
Opinion (259)
Patents (145)
People (64513)
Pharmaceutical (132)
Phase I (22311)
Phase II (31403)
Phase III (23596)
Pipeline (655)
Postmarket research (3541)
Preclinical (10015)
Radiopharmaceuticals (248)
Rare diseases (317)
Real estate (7376)
Regulatory (26179)
Research institute (2641)
Resumes & cover letters (649)
Southern California (1595)
Startups (4278)
United States (16601)
Vaccines (669)
Weight loss (205)
Date
Last 7 days (510)
Last 30 days (2089)
Last 365 days (32509)
2025 (3770)
2024 (34425)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1262)
Arizona (226)
Asia (49575)
Australia (8751)
California (4264)
Canada (1414)
China (375)
Colorado (189)
Connecticut (181)
Europe (113440)
Florida (525)
Georgia (120)
Illinois (407)
Indiana (230)
Maryland (721)
Massachusetts (3425)
Michigan (176)
Minnesota (284)
New Jersey (1219)
New York (1216)
North Carolina (894)
Northern California (1864)
Ohio (144)
Pennsylvania (928)
South America (1646)
Southern California (1595)
Texas (588)
Washington State (455)
834,517 Results for "bio tissue".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Drug Development
Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases
Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced the publication of preclinical data in Molecular Therapy that further validates the therapeutic potential of ADX-097, a tissue-targeted complement inhibitor.
February 21, 2024
·
11 min read
Press Releases
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers
January 10, 2025
·
15 min read
Press Releases
RS BioTherapeutics Announces Positive Anti-Inflammatory and Anti-Fibrotic Effects of Lead Compound in Human Lung Tissue
January 21, 2025
·
3 min read
Press Releases
FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials
January 6, 2025
·
3 min read
Press Releases
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
February 10, 2025
·
6 min read
Press Releases
Adela to Present Biological Insights into its Tissue-Agnostic Assay for Molecular Residual Disease Detection at the AACR Special Conference in Cancer Research
November 15, 2024
·
3 min read
Business
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer.
May 20, 2024
·
5 min read
Press Releases
Cathay Biotech to showcase thermoplastic bio-based composite materials (bio-PPA CFRT) at 2025 JEC World
February 11, 2025
·
2 min read
Business
TELA Bio Reports First Quarter 2024 Financial Results
TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
8 min read
1 of 83,452
Next
